HopeStage
Back to all studies
RecruitingNCT06136247

Brain and thinking measures in people receiving opioid treatment

About this titleRead the official source — NCT06136247
Observational studyAges 18–60United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
PhiladelphiaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
192
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Observational
Intervention type
DIAGNOSTIC_TEST
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT06136247
Official title
Show the full official title

Integrating Brain, Neurocognitive, and Computational Tools in Opioid Use Disorder (OUD) to Characterize Executive Function and to Predict Clinical Outcomes.

Recruitment & locations

Currently recruiting

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies